ADVERTISEMENT

Medical News

New COVID-19 vaccine shows good efficacy and toxicity profile

Dawn O'Shea   |   18 November 2021

A randomised, double-blind, placebo-controlled, multicentre, phase 3 clinical trial has found that a new SARS-CoV-2 vaccine is “highly efficacious against laboratory-confirmed symptomatic COVID-19 disease”.

Covaxin (codenamed BBV152) is a whole virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist molecule adsorbed with alum (Algel-IMDG). It has been developed...

          

November Challenge

Ends in 1d 7h
left
right

Topic Challenges

left
right